How to inject the Mounjaro single dose pen correctly

Choosing where to inject, and why it matters

The three approved sites each have practical differences worth knowing before you commit. The abdomen tends to give the most consistent subcutaneous access for most people; the thigh is easy to see and steady on your own; the upper arm usually requires someone else's help unless you're confident bracing against a surface. The rule that cuts across all three is rotation: returning to exactly the same spot week after week can cause lipohypertrophy, a build-up of scar-like fatty tissue that slows absorption. NHS guidance on tirzepatide on the NHS medicines pages recommends moving the site each week within or between those three areas.

A few practical distances matter. Stay at least 5 cm from your navel when using the abdomen, and avoid injecting directly into a mole, scar, bruise, or area of broken skin. If you're using the thigh, the front-outer quadrant gives the clearest access. Starting a new pen at a different site from the last one is a simple habit that protects the skin over months of weekly treatment. If you're uncertain about your specific anatomy or have had any skin procedures, the question is worth raising through our support team before your next injection day.

The injection itself: what to do, step by step

Remove the pen from the fridge around 30 minutes before you plan to inject, a pen at room temperature is more comfortable than one straight from cold storage. Check the viewing window: the liquid should be clear or faintly yellow and free of visible particles. If it looks cloudy or contains lumps, don't use that pen.

Peel the foil tab from the needle cap (each KwikPen has a needle already attached under the cap) and remove both the outer and inner needle shields. Pinch a fold of skin at your chosen site. Press the base of the pen firmly and flat against the skin, then press and hold the purple injection button. A click signals the start; keep the pen held steady until a second click confirms the dose is delivered, and hold for a further 10 seconds before removing. The yellow indicator in the viewing window will have moved to show the dose is complete.

There's no need to rub the site afterwards. Place the used pen straight into a sharps container, the needle is covered automatically as you remove the pen, but disposal via sharps bin remains the correct and legal route. Your pen arrives from us by DPD the next working day in plain, unbranded packaging with tracking sent to your phone, so it's simple to plan exactly when you'll be home.

The decision you're really making at dose-change points

Tirzepatide starts at 2.5 mg, a dose whose job is to let your body adjust rather than produce the main therapeutic effect. When a prescriber moves you to a higher strength, the injection technique stays the same, but the pen is different. The Mounjaro single dose pen format is consistent across all strengths; what changes is the cartridge inside. This is why a clinical review precedes every dose increase at nume: it's not just paperwork, it's confirmation that the previous dose was tolerated and that progression is appropriate.

People sometimes ask whether the injection hurts more at higher doses. In practice, the sensation is driven more by site choice, skin temperature, and injection speed than by dose level. Slow, steady button pressure and allowing the pen to reach room temperature beforehand tend to reduce discomfort more reliably than anything else.

If you're on your starting 2.5 mg and want to understand what the early weeks typically look like in practice, the 2.5 mg injection guide covers the specifics of that first pen. For anyone mid-titration working out their second pen of a new strength, the second-dose guide addresses the most common questions at that point. If you've reached the highest strength and need guidance on mixing 30 mg tirzepatide correctly, that process has its own dedicated page covering everything you need before you begin. The cost context of private tirzepatide treatment (and what a transparent price actually covers) is covered on the Mounjaro treatment page.

When to pause and get help

Most injection-related concerns are minor: a small bruise, brief stinging, or a raised patch that fades within an hour. A few signs are worth acting on promptly. Severe stomach pain that extends through to the back (with or without vomiting) should be assessed urgently; in January 2026, the MHRA issued a Drug Safety Update for GLP-1 medicines specifically flagging acute pancreatitis as an infrequent but serious risk. Signs of an allergic reaction (swelling of the face, throat, or lips, or difficulty breathing) warrant emergency help. Persistent injection-site reactions that don't settle after a few days, or skin changes appearing at rotation sites, are worth discussing with your prescriber before your next dose.

You can report any suspected side effect from a licensed medicine directly through the MHRA's Yellow Card scheme, it's open to patients, not just clinicians, and contributes to ongoing safety monitoring. Our prescribers are available seven days a week for aftercare questions through the FAQs or directly via support if something needs clinical input. That's not an add-on, it's part of what treatment with us includes.

If you're considering tirzepatide and haven't yet had a clinical assessment, speaking to our prescribers is the place to start.